NEW
Phesgo

Phesgo Description

pertuzumab + trastuzumab

Manufacturer:

Roche

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
Single dose vials contain: 1200 mg pertuzumab/600 mg trastuzumab/15 mL solution in a vial.
600 mg pertuzumab/600 mg trastuzumab/10 mL solution in a vial.
Sterile/Radioactive Statement: Sterile Product.
Excipients: Phesgo contains vorhyaluronidase alfa (recombinant human hyaluronidase rHuPH20), an enzyme used to increase the dispersion and absorption of co-formulated drugs when administered subcutaneously.
Excipients/Inactive Ingredients: L-Histidine, L-Histidine Hydrochloride Monohydrate, α,α-Trehalose Dihydrate, Sucrose, Polysorbate 20, L-Methionine, Water for Injection.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in